4.7 Review

The Endocannabinoid System as a Target for Neuroprotection/Neuroregeneration in Perinatal Hypoxic-Ischemic Brain Injury

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Pharmacology & Pharmacy

A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD)

Jiangling Peng et al.

Summary: CBD, an abundant non-psychoactive phytocannabinoid in cannabis extracts, has multiple therapeutic effects and potential applications in human diseases such as neuroprotection, antiepileptic, and anxiolytic properties. This narrative review summarizes the applications of CBD in human diseases from mechanism of action to clinical trials.

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2022)

Review Pediatrics

New possibilities for neuroprotection in neonatal hypoxic-ischemic encephalopathy

Suresh Victor et al.

Summary: Around 0.75 million babies suffer from HIE each year, leading to neurodevelopmental impairment. Therapeutic hypothermia is effective but improvements are needed. Challenges for the next decade include better animal models, industry support, and well-designed clinical trials to enhance treatment outcomes.

EUROPEAN JOURNAL OF PEDIATRICS (2022)

Review Pharmacology & Pharmacy

Endocannabinoid-Based Therapies

Daniele Piomelli et al.

Summary: Endocannabinoids are lipid-derived messengers that regulate various physiological processes in mammals. Dysfunctions in their activity have been linked to diseases, leading to interest in the endocannabinoid system as a potential source of therapeutic drugs. This review provides an overview of endocannabinoid formation, deactivation, and biotransformation, and discusses the properties and therapeutic potential of pharmacological agents that interfere with these processes.

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2022)

Article Biochemistry & Molecular Biology

Defining Steric Requirements at CB1 and CB2 Cannabinoid Receptors Using Synthetic Cannabinoid Receptor Agonists 5F-AB-PINACA, 5FADB-PINACA, PX-1, PX-2, NNL-1, and Their Analogues

Jack Markham et al.

Summary: The study explored the contribution of the amino acid side chain to the cannabinoid pharmacology of synthetic cannabinoid receptor agonists (SCRAs). A systematic library of side chain-modified SCRAs was prepared and experiments revealed significant variations in binding affinities and functional activities across compounds, with clear structure-activity relationships (SARs) emerging. The findings provide insights into the structural contributions to the cannabimimetic profiles of SCRAs and other related compounds.

ACS CHEMICAL NEUROSCIENCE (2022)

Article Biochemical Research Methods

Cannabinoid receptor activation potential of the next generation, generic ban evading OXIZID synthetic cannabinoid receptor agonists

Marie H. Deventer et al.

Summary: In recent years, countries have implemented measures to control the increase of new synthetic cannabinoid receptor agonists (SCRAs) in the recreational drug market. China implemented a new legislation in July 2021, banning SCRAs with seven core scaffolds. This study reports on the potency and efficacy of five members of a new class of SCRAs, providing important information for public health officials, law enforcement agencies, and clinicians.

DRUG TESTING AND ANALYSIS (2022)

Article Biochemistry & Molecular Biology

Cannabinoids: Therapeutic Use in Clinical Practice

Cristina Pagano et al.

Summary: Medical case reports suggest that cannabinoids extracted from Cannabis sativa have therapeutic effects, but their use is limited due to the psychotropic effect of its major component THC. New scientific discoveries have led to the development of new therapeutic targets to minimize the undesirable effects of certain constituents. FDA-approved drugs have shown efficacy in treating multiple sclerosis, cancer, and AIDS-related anorexia. This review highlights the potential therapeutic efficacy of cannabinoids in various diseases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Pediatrics

Neurogenesis Is Reduced at 48 h in the Subventricular Zone Independent of Cell Death in a Piglet Model of Perinatal Hypoxia-Ischemia

Daniel Alonso-Alconada et al.

Summary: Hypoxia-ischemia can lead to a decrease in cell proliferation and neurogenesis in the neurogenic niche of the neonatal piglet, which may hinder the replacement of lost neurons and overall repair.

FRONTIERS IN PEDIATRICS (2022)

Review Pharmacology & Pharmacy

Targeting Endocannabinoid Signaling: FAAH and MAG Lipase Inhibitors

Noelle van Egmond et al.

Summary: Researchers have developed compounds to modulate the endocannabinoid system in the human brain, including inhibitors of FAAH and MAGL to exert therapeutic effects without inducing adverse reactions associated with direct stimulation of the CB1 receptor by THC. These compounds have potential for treatment without the side effects of THC.

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 61, 2021 (2021)

Review Neurosciences

Current Therapies for Neonatal Hypoxic-Ischaemic and Infection-Sensitised Hypoxic-Ischaemic Brain Damage

Konstantina Tetorou et al.

Summary: Neonatal hypoxic-ischaemic brain damage is a major cause of child mortality and morbidity, often resulting from impaired cerebral perfusion due to issues with the uterus, placenta, or umbilical cord during delivery. Bacterial infection is a contributing factor that worsens neuronal damage in cases of hypoxic-ischaemic injury.

FRONTIERS IN SYNAPTIC NEUROSCIENCE (2021)

Review Behavioral Sciences

Modern approaches to the development of synthetic cannabinoid receptor probes

Savanah L. Saldana-Shumaker et al.

Summary: This review highlights recent advances in synthetic cannabinoid receptor chemistry and pharmacology, including new CB1R and CB2R selective probes, rational approaches to the design of peripherally-restricted agents, and structural classes of positive and negative allosteric modulators of CB1R and CB2R.

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2021)

Review Pharmacology & Pharmacy

Cannabidiol for the Treatment of Neonatal Hypoxic-Ischemic Brain Injury

Jose Martinez-Orgado et al.

Summary: CBD shows neuroprotective effects in newborn pigs and rodents with HIBI, modulating the major components of HIBI pathophysiology. It has the potential to be an effective treatment for neonatal HIBI.

FRONTIERS IN PHARMACOLOGY (2021)

Review Chemistry, Medicinal

Pharmacology and adverse effects of new psychoactive substances: synthetic cannabinoid receptor agonists

Eun Yong Chung et al.

Summary: New psychoactive substances (NPS), including synthetic cannabinoid receptor agonists (SCRAs) among others, have been a focus of international attention in the past decade. These substances are sold as legal highs and research chemicals, with most commonly abused SCRAs associated with severe toxicities. Systematic studies on the adverse effects of NPS are lacking, highlighting the need for more research and understanding of these substances to address associated health issues.

ARCHIVES OF PHARMACAL RESEARCH (2021)

Review Neurosciences

Pharmacological selection of cannabinoid receptor effectors: Signalling, allosteric modulation and bias

Jamie J. Manning et al.

Summary: The CB1 receptor is a promising drug target for a wide range of diseases, but existing ligands have limited therapeutic potential. Recent drug development efforts have focused on altering CB1 signaling by modulating endocannabinoid signaling or selectively targeting specific cellular pathways.

NEUROPHARMACOLOGY (2021)

Review Neurosciences

A systematic review of neurogenesis in animal models of early brain damage: Implications for cerebral palsy

Diego Bulcao Visco et al.

Summary: Early brain damage is a key factor in the development of cerebral palsy. Research suggests that prenatal brain damage affects neurogenesis, while postnatal models exhibit increased proliferation of neural precursor cells, improper migration, and reduced survival of new neurons.

EXPERIMENTAL NEUROLOGY (2021)

Review Biochemistry & Molecular Biology

Cannabinoid Receptors in Myocardial Injury: A Brother Born to Rival

Xinru Tang et al.

Summary: Cannabinoid receptors, including CB1 and CB2, play important roles not only in the central nervous system and immune system, but also in myocardial injuries. Despite sharing some sequence or location identity, these "brother" receptors have significant differences and sometimes antagonistic functions, highlighting the importance of individual receptor-based modulation in treating myocardial injuries.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Biochemistry & Molecular Biology

The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases

Henry Lowe et al.

Summary: The Endocannabinoid System (ECS) plays a crucial role in maintaining internal balance in biological systems and is implicated in various diseases. In recent years, there has been significant interest in manipulating the ECS for medical purposes, offering promising opportunities for developing novel cannabinoid-based therapeutic drugs for the treatment of a range of diseases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Pharmacology & Pharmacy

Natural and Synthetic Cannabinoids: Pharmacology, Uses, Adverse Drug Events, and Drug Interactions

Joshua D. Brown et al.

Summary: This narrative review discusses the current use environment and potential risks of natural and synthetic cannabinoids, mentioning the applications of natural cannabinoids in medical and consumer products, as well as the pharmacological differences and potential dangers of synthetic cannabinoids compared to natural cannabinoids.

JOURNAL OF CLINICAL PHARMACOLOGY (2021)

Review Chemistry, Medicinal

Pharmacological properties, therapeutic potential, and legal status of Cannabis sativa L.: An overview

Pradeep Kumar et al.

Summary: Marijuana, or Cannabis sativa L., is a psychoactive plant used for recreational and medicinal purposes, with potential therapeutic effects on various diseases. Understanding the pharmacological mechanisms and interactions with other drugs is essential for fully utilizing marijuana's medicinal potential.

PHYTOTHERAPY RESEARCH (2021)

Article Clinical Neurology

The synthetic CB1 cannabinoid receptor selective agonists: Putative medical uses and their legalization

Astrid Coronado-Alvarez et al.

Summary: Δ9-THC, the major component of Cannabis sativa, exerts biological effects through activation of cannabinoid receptors CB1 and CB2. Synthetic CB1 cannabinoid receptor selective agonists show potential in therapeutic approaches, but concerns regarding side effects still exist despite positive results in experimental models and preclinical trials.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2021)

Article Medicine, Research & Experimental

Neuroprotective effects of minocycline and KML29, a potent inhibitor of monoacylglycerol lipase, in an experimental stroke model: a small-animal positron emission tomography study

Tomoteru Yamasaki et al.

Summary: Hypoxia-induced ischemia leads to neuronal death in the CNS through acidosis and neuroexcitotoxicity. This study used PET imaging to monitor MAGL-positive neurons and neuroinflammation in ischemic rats, finding that treatment with MAGL inhibitors had neuroprotective effects. PET imaging showed that minocycline and KML29 treatments had different effects on neuronal protection in the brain following ischemic injury.

THERANOSTICS (2021)

Review Biochemistry & Molecular Biology

CB1 Cannabinoid Receptor Signaling and Biased Signaling

Luciana M. Leo et al.

Summary: The CB1 cannabinoid receptor is a promising therapeutic target for various disorders, but the development of drug candidates is hindered by challenges such as adverse effects and rapid tolerance. Biased signaling analysis may help dissociate therapeutic and adverse effects, but the mechanism of biased signaling at the CB1 receptor remains poorly understood at present.

MOLECULES (2021)

Article Nanoscience & Nanotechnology

Neuroprotective Effects of VEGF-A Nanofiber Membrane and FAAH Inhibitor URB597 Against Oxygen-Glucose Deprivation-Induced Ischemic Neuronal Injury

Da-Peng Wang et al.

Summary: The VEGF modified NF membrane and URB597 showed positive synergistic neuroprotective effects by inhibiting mitochondrial oxidative stress and activating CB1R/PI3K/AKT/BDNF signaling pathways, suggesting that they could be therapeutic in ischemic cerebrovascular diseases.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2021)

Review Chemistry, Medicinal

A perspective review on fatty acid amide hydrolase (FAAH) inhibitors as potential therapeutic agents

Rati Kailash Prasad Tripathi

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

Review Pharmacology & Pharmacy

The therapeutic potential of second and third generation CB1R antagonists

Resat Cinar et al.

PHARMACOLOGY & THERAPEUTICS (2020)

Review Biochemistry & Molecular Biology

Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection?

Francesca Rossi et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Toxicology

The synthetic cannabinoids phenomenon: from structure to toxicological properties. A review

Vera L. Alves et al.

CRITICAL REVIEWS IN TOXICOLOGY (2020)

Review Biochemistry & Molecular Biology

Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products

Dongchen An et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Multidisciplinary Sciences

Cannabinoids and Cannabinoid Receptors: The Story so Far

Fred Shahbazi et al.

ISCIENCE (2020)

Review Plant Sciences

Phytocannabinoids: Origins and Biosynthesis

Thies Gulck et al.

TRENDS IN PLANT SCIENCE (2020)

Review Behavioral Sciences

Therapeutic potential and safety considerations for the clinical use of synthetic cannabinoids

Dennis J. Sholler et al.

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2020)

Review Pharmacology & Pharmacy

New psychoactive substances: a review and updates

Abu Shafi et al.

THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2020)

Article Neurosciences

Neurobiology of cannabinoid receptor signaling

Beat Lutz

DIALOGUES IN CLINICAL NEUROSCIENCE (2020)

Review Clinical Neurology

Neuroprotection Strategies for Term Encephalopathy

Fernando F. Gonzalez

SEMINARS IN PEDIATRIC NEUROLOGY (2019)

Review Cell Biology

Medical Cannabis: A plurimillennial history of an evergreen

S. Pisanti et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2019)

Review Biochemistry & Molecular Biology

Functional Relevance of Endocannabinoid-Dependent Synaptic Plasticity in the Central Nervous System

Shana M. Augustin et al.

ACS CHEMICAL NEUROSCIENCE (2018)

Review Pharmacology & Pharmacy

Cannabinoid signalling in the immature brain: Encephalopathies and neurodevelopmental disorders

Onintza Sagredo et al.

BIOCHEMICAL PHARMACOLOGY (2018)

Article Pharmacology & Pharmacy

Therapeutic Use of Synthetic Cannabinoids: Still an Open Issue?

Maria Antonietta De Luca et al.

CLINICAL THERAPEUTICS (2018)

Article Biochemistry & Molecular Biology

Effects of monoacylglycerol lipase inhibitor URB602 on lung ischemia-reperfusion injury in mice

Yaqin Xiong et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)

Review Cardiac & Cardiovascular Systems

Endocannabinoids in cerebrovascular regulation

Zoltan Benyo et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2016)

Review Neurosciences

An Introduction to the Endogenous Cannabinoid System

Hui-Chen Lu et al.

BIOLOGICAL PSYCHIATRY (2016)

Review Biochemistry & Molecular Biology

The CB2 receptor and its role as a regulator of inflammation

Caroline Turcotte et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2016)

Review Neurosciences

Traumatic Brain Injury Activation of the Adult Subventricular Zone Neurogenic Niche

Eun Hyuk Chang et al.

FRONTIERS IN NEUROSCIENCE (2016)

Review Clinical Neurology

Injury-Induced Neurogenesis: Mechanisms and Relevance

Tzong-Shiue Yu et al.

NEUROSCIENTIST (2016)

Article Neurosciences

Mechanisms of Mouse Neural Precursor Expansion after Neonatal Hypoxia-Ischemia

Krista D. Buono et al.

JOURNAL OF NEUROSCIENCE (2015)

Review Pediatrics

Hypoxic-Ischemic Encephalopathy A Review for the Clinician

Martha Douglas-Escobar et al.

JAMA PEDIATRICS (2015)

Review Clinical Neurology

Therapeutic hypothermia for neonatal hypoxic-ischemic encephalopathy - where to from here?

Joanne O. Davidson et al.

FRONTIERS IN NEUROLOGY (2015)

Article Obstetrics & Gynecology

Mechanisms of Hypothermic Neuroprotection

Paul P. Drury et al.

CLINICS IN PERINATOLOGY (2014)

Article Neurosciences

Odor Processing by Adult-Born Neurons

Yoav Livneh et al.

NEURON (2014)

Article Biochemistry & Molecular Biology

Evaluation of NHS Carbamates as a Potent and Selective Class of Endocannabinoid Hydrolase Inhibitors

Micah J. Niphakis et al.

ACS CHEMICAL NEUROSCIENCE (2013)

Article Anatomy & Morphology

Adult Neural Stem Cells From the Subventricular Zone: A Review of the Neurosphere Assay

Sara Gil-Perotin et al.

ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2013)

Article Biochemistry & Molecular Biology

Dynamics of Hippocampal Neurogenesis in Adult Humans

Kirsty L. Spalding et al.

Article Neurosciences

Chondroitin sulfate proteoglycans inhibit oligodendrocyte myelination through PTPσ

James C. Pendleton et al.

EXPERIMENTAL NEUROLOGY (2013)

Review Biochemistry & Molecular Biology

Neuroprotective Effect of Melatonin: A Novel Therapy against Perinatal Hypoxia-Ischemia

Daniel Alonso-Alconada et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)

Review Neurosciences

Cannabinoids: Well-Suited Candidates for the Treatment of Perinatal Brain Injury

David Fernandez-Lopez et al.

BRAIN SCIENCES (2013)

Article Biochemistry & Molecular Biology

The Cannabinoid WIN 55212-2 Mitigates Apoptosis and Mitochondrial Dysfunction After Hypoxia Ischemia

D. Alonso-Alconada et al.

NEUROCHEMICAL RESEARCH (2012)

Review Neurosciences

Endocannabinoid Signaling and Synaptic Function

Pablo E. Castillo et al.

NEURON (2012)

Article Pharmacology & Pharmacy

Type-1 Cannabinoid Receptor Signaling in Neuronal Development

Anne-Lise Gaffuri et al.

PHARMACOLOGY (2012)

Review Biology

Endocannabinoids via CB1 receptors act as neurogenic niche cues during cortical development

Javier Diaz-Alonso et al.

PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2012)

Article Endocrinology & Metabolism

Therapeutic hypothermia influences cell genesis and survival in the rat hippocampus following global ischemia

Gergely Silasi et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2011)

Article Neurosciences

Polymodal activation of the endocannabinoid system in the extended amygdala

Nagore Puente et al.

NATURE NEUROSCIENCE (2011)

Article Clinical Neurology

The Cannabinoid WIN55212-2 Promotes Neural Repair After Neonatal Hypoxia-Ischemia

David Fernandez-Lopez et al.

STROKE (2010)

Review Chemistry, Medicinal

Therapeutic Potential of Non-Psychotropic Cannabidiol in Ischemic Stroke

Kazuhide Hayakawa et al.

PHARMACEUTICALS (2010)

Review Biochemistry & Molecular Biology

Post-ischemic brain damage: the endocannabinoid system in the mechanisms of neuronal death

Domenico E. Pellegrini-Giampietro et al.

FEBS JOURNAL (2009)

Letter Biochemical Research Methods

'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs?

Volker Auwaerter et al.

JOURNAL OF MASS SPECTROMETRY (2009)

Article Biochemistry & Molecular Biology

Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects

Jonathan Z. Long et al.

NATURE CHEMICAL BIOLOGY (2009)

Article Geography, Physical

Vegetation and climate dynamics during the Holocene and Eemian interglacials derived from Lake Baikal pollen records

P. Tarasov et al.

PALAEOGEOGRAPHY PALAEOCLIMATOLOGY PALAEOECOLOGY (2007)

Article Biochemistry & Molecular Biology

The CB1 cannabinoid receptor mediates excitotoxicity-induced neural progenitor proliferation and neurogenesis

Tania Aguado et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2007)

Article Multidisciplinary Sciences

Hardwiring the brain:: Endocannabinoids shape neuronal connectivity

Paul Berghuis et al.

SCIENCE (2007)

Review Neurosciences

Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597)

Daniele Piomelli et al.

CNS DRUG REVIEWS (2006)

Article Pharmacology & Pharmacy

Molecular mechanisms of cannabinoid protection from neuronal excitotoxicity

SH Kim et al.

MOLECULAR PHARMACOLOGY (2006)

Article Multidisciplinary Sciences

Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis

G Gobbi et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Article Multidisciplinary Sciences

Identification and functional characterization of brainstem cannabinoid CB2 receptors

MD Van Sickle et al.

SCIENCE (2005)

Article Biochemistry & Molecular Biology

Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation

SA Back et al.

NATURE MEDICINE (2005)

Article Multidisciplinary Sciences

An endocannabinoid mechanism for stress-induced analgesia

AG Hohmann et al.

NATURE (2005)

Review Pharmacology & Pharmacy

Cannabinoids and neuroinflammation

L Walter et al.

BRITISH JOURNAL OF PHARMACOLOGY (2004)

Article Endocrinology & Metabolism

Neural stem cells in the subventricular zone are resilient to hypoxia/ischemia whereas progenitors are vulnerable

MJ Romanko et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2004)

Article Developmental Biology

Perinatal hypoxia/ischemia damages and depletes progenitors from the mouse subventricular zone

CY Brazel et al.

DEVELOPMENTAL NEUROSCIENCE (2004)

Review Neurosciences

The molecular logic of endocannabinoid signalling

D Piomelli

NATURE REVIEWS NEUROSCIENCE (2003)

Article Biochemistry & Molecular Biology

Modulation of anxiety through blockade of anandamide hydrolysis

S Kathuria et al.

NATURE MEDICINE (2003)

Article Multidisciplinary Sciences

Brain monoglyceride lipase participating in endocannabinoid inactivation

TP Dinh et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)

Article Multidisciplinary Sciences

Cell proliferation without neurogenesis in adult primate neocortex

DR Kornack et al.

SCIENCE (2001)

Article Multidisciplinary Sciences

Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase

BF Cravatt et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)

Review Biochemistry & Molecular Biology

2-arachidonoylglycerol and the cannabinoid receptors

T Sugiura et al.

CHEMISTRY AND PHYSICS OF LIPIDS (2000)

Review Biochemistry & Molecular Biology

Ligand-receptor signaling with endocannabinoids in preimplantation embryo development and implantation

BC Paria et al.

CHEMISTRY AND PHYSICS OF LIPIDS (2000)

Review Neurosciences

The endogenous cannabinoid system and brain development

J Fernandez-Ruiz et al.

TRENDS IN NEUROSCIENCES (2000)